Paradeep Phosph.
Paradeep Phosph. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
Company expects higher traded volumes going forward, significantly above last year, aiding volume growth without pressuring EBITDA per ton due to supply chain efficiencies (Page 17). Paradeep Phosphates Limited expects sustainable EBITDA of around Rs.5,000 per ton by the end of FY27, supported by supply chain efficiencies and backward integration (Pages 7, 14, 17).
From Paradeep Phosph.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Company expects higher traded volumes going forward, significantly above last year, aiding volume growth without pressuring EBITDA per ton due to supply chain efficiencies (Page 17).
- Total fertilizer sales volume grew 13% YoY despite flat industry volume, driven by balanced market presence across India and strong brand development (Page 11).
- Focus on increasing NPK adoption driven by farmer awareness on soil health and balanced nutrition, though short-term price caps on DAP affect portfolio mix; long-term balanced portfolio expected post price normalization (Page 17).
- Capacity expansions underway: phosphoric acid capacity to increase from 5 to 7 lakh tons by FY27 end (December), granulation capacity expansion from 3.7 to 4 lakh tons expected by December (Page 16, 11).
- Company aims to maintain sustainable EBITDA of around Rs.5,000 per ton, improving post expansion projects (Page 11, 16).
- Robust import pipeline of ~0.5 million tons secured for rabi season to supplement demand (Page 13).
Profitability & Margins
See what Paradeep Phosph. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Approved Rs.250 crores investment for setting up an aluminium fluoride plant at Paradeep facility; targeted commissioning within 22-24 months, with expected revenue of Rs.180-200 crores and EBITDA around Rs.50 crores.
- Phosphoric acid expansion project (phase-I) increasing capacity from 5 lakh tons to 7 lakh tons is on track, with 1 lakh ton expansion expected by December and another 1 lakh ton by next August in FY27.
- Granulation capacity debottlenecking from 3.7 to 4 lakh tons expected by December FY27; contract awarded and work ongoing.
- Larger expansion projects worth Rs.3,500-3,600 crores planned for FY29-30, expected in phases by mid FY29-30.
- Focus on backward integration (e.g., sulphuric acid) to improve supply security and profitability.
- Strategic intent to diversify into non-subsidy industrial chemicals to build a 20% non-subsidy EBITDA contribution over long term.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Paradeep Phosph. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company has secured around half a million tons of imports for traded products to support Q2 and Q3 up to December (Page 13).
- Management is focusing on optimizing market requirements by balancing manufactured and imported volumes given supply chain disruptions and raw material costs (Page 14).
- No explicit orderbook value or pending orders figure was disclosed, but traded volumes are expected to be significantly higher this year compared to last year, indicating robust demand and operational activity (Page 17).
- The company is progressing with expansion projects including debottlenecking granulation capacity by December and phosphoric acid capacity augmentation by December (Pages 15 and 11).
- Overall, the company is strategically managing its order execution through a combination of manufacturing and trading to maintain market share amid global disruptions (Pages 13-14, 17).
Paradeep Phosph. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹4.7K Cr, net profit ₹156 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Paradeep Phosphates Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Indogulf Cropsciences Ltd (Q1 FY27)
1800+ crores within 2-3 years. Key concall takeaways from Indogulf Cropsciences Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Gujarat State Fertilizers & Chemicals Ltd (Q1 FY27)
Profit after tax increased by 15% YoY in Q1 FY27, signaling positive growth trajectory. Key concall takeaways from Gujarat State Fertilizers & Chemicals Ltd's…
- GSP Crop Science Ltd (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
- Rallis India Ltd (Q1 FY27)
. Key concall takeaways from Rallis India's Q1 FY27 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Paradeep Phosph. Q1 FY27 results?
Company expects higher traded volumes going forward, significantly above last year, aiding volume growth without pressuring EBITDA per ton due to supply chain efficiencies (Page 17). Paradeep Phosphates Limited expects sustainable EBITDA of around Rs.5,000 per ton by the end of FY27, supported by supply chain efficiencies and backward integration (Pages 7, 14, 17).
What is Paradeep Phosph. share price analysis?
Paradeep Phosph. currently shows a below-average growth signal. The stock trades at a P/E of 14.2 with a market cap of ₹15,420 Cr. Investors should review the full earnings analysis for detailed insights.
Is Paradeep Phosph. planning capital expenditure?
Approved Rs.250 crores investment for setting up an aluminium fluoride plant at Paradeep facility; targeted commissioning within 22-24 months, with expected revenue of Rs.180-200 crores and EBITDA around Rs.50 crores.
Keep Paradeep Phosph. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.